Identification of novel SIRT3 inhibitor scaffolds by virtual screening

• Published in: Bioorganic & medicinal chemistry letters 2013-05, Vol.23 (10), p.2990-2995
• Main Authors: Salo, Heikki S., Laitinen, Tuomo, Poso, Antti, Jarho, Elina, Lahtela-Kakkonen, Maija
• Format: Article
• Language: English
• Subjects: Animals; Benzoxazoles - chemistry; Benzoxazoles - pharmacology; breast neoplasms; chemistry; Crystallography, X-Ray; Docking; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors - chemistry; Enzyme Inhibitors - pharmacology; histone deacetylase; homeostasis; Humans; in vitro studies; Inhibitor scaffold; Mice; Models, Molecular; Molecular Structure; screening; Shape matching; SIRT3; Sirtuin 3 - antagonists & inhibitors; Sirtuin 3 - metabolism; squamous cell carcinoma; Structure-Activity Relationship; Virtual screening
• ISSN: 0960-894X; 1464-3405
• DOI: 10.1016/j.bmcl.2013.03.033

SIRT3 is a member of the sirtuin family of histone deacetylases. It is a mitochondrial protein, which has an important role in metabolic homeostasis but it may also act as a tumor suppressor or promoter. Increased SIRT3 transcription has been associated with node-positive breast cancer and oral squamous cell carcinoma. To identify novel SIRT3 inhibitors we have established a virtual screening workflow by using shape-based filtering and flexible docking protocol. The Chembridge database was screened and 40 molecules were selected and tested in an in vitro assay. Two novel scaffolds were identified among the tested hits. The 5-amino-2-phenyl-benzoxazole scaffold was selected for further structure–activity studies and a series of its analogs was tested. The SIRT3 inhibition for this series ranged between 13% and 71%.